CIK 0001771910 · Non-accelerated filer<br>Smaller reporting company
ADC Therapeutics SA
Sign in to watch- Ticker
- ADCT
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- Phone
- 41 21 653 02 00
- Business address
- BIOPOLE, ROUTE DE LA CORNICHE 3B, EPALINGES, Switzerland, 1066
- 4 Grant or award Chief Medical Officer acquired 213,900 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 221,100 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 203,700 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 675,000 shares (grant or award)
- 4 Shares withheld for taxes Director gave up 12,600 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 15,196 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 12,600 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 2,596 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 2,156 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 12,600 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 12,600 shares (to pay taxes)
- 4 Open-market sale 10% owner sold 5,880,415 shares at an average $3.34 ($19,636,340)
- 4 Grant or award Chief Accounting Officer acquired 62,900 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 285,200 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 294,800 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 271,600 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 900,000 shares (grant or award)
- 4 Shares withheld for taxes Chief Executive Officer gave up 233,146 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 41,068 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 7,140 shares (to pay taxes)
Page 1 of 5 · 88 filings